Document is current
Any future updates will be listed below
-
Authors
Masalkhi, Mouayad https://orcid.org/0000-0003-0811-358X
Ong, Joshua https://orcid.org/0000-0003-4860-827X
Waisberg, Ethan https://orcid.org/0000-0001-8999-0212
Lee, Andrew G.
- License Information
-
More Information
Article History
Received: 28 May 2024
Revised: 3 June 2024
Accepted: 21 June 2024
First Online: 29 June 2024
Competing interests
: AGL is a consultant for the National Aeronautics and Space Administration (NASA) and has the following additional disclosures: Amgen (speaker), Alexion (speaker), Viridian, Stoke, Astrazeneca, and Bristol Myers Squibb. AGL is also an Editor for the journal <i>Eye</i>. The other authors declare no competing interests.
